Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 78 of 78 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 06/28/13
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 08/31/11
Due: 08/31/12
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE) | NCT02126358 | LG Life Sciences | user2@example.com | None | 2014-05-31 | 2016-03-31 | 2017-03-31 | - | - | 2025-07-14 |
| An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin | NCT02290301 | LG Life Sciences | user2@example.com | None | 2013-06-28 | 2017-11-30 | 2018-11-30 | - | - | 2025-07-14 |
| Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers | NCT01342055 | LG Life Sciences | user2@example.com | None | 2011-03-31 | 2011-08-31 | 2012-08-31 | - | - | 2025-07-14 |